UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 30, 2026
Sale
Calculated transaction value
$468.36K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 29, 2026
Public filing date
Jul 30, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$524.7
Jul 29, 2026
Close before public filing
$524.7
Jul 29, 2026
Return since public filing
-5.26%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 900 shares @ $520.4
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000109
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.25M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Jul 29, 2026 | $1.04M |
| United Therapeutics Corp UTHR | Sale | Jul 29, 2026 | $662.08K |
| United Therapeutics Corp UTHR | Sale | Jul 29, 2026 | $651.57K |
| United Therapeutics Corp UTHR | Sale | Jul 29, 2026 | $459.81K |
| United Therapeutics Corp UTHR | Exercise | Jul 29, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Jul 29, 2026 | $413.56K |
| United Therapeutics Corp UTHR | Sale | Jul 29, 2026 | $690.14K |
| United Therapeutics Corp UTHR Current | Sale | Jul 29, 2026 | $468.36K |
| United Therapeutics Corp UTHR | Exercise | Jul 29, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 29, 2026 | $577.45K |